Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 16-02-01 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 15-07-09 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.87M 1.72M 1.61M 3.02M 201M 3.08M 20.67M 8M 99.22M 7.99M 7.82M 344M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.91M 5.45M 5.1M 9.57M 636M 9.77M 65.5M 25.35M 314M 25.32M 24.77M 1.09B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 2015-03-31 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 2011-06-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 1991-05-28 |
Sidney Emery
BRD | Director/Board Member | 76 | 2005-10-02 |
| Director/Board Member | 59 | 2010-08-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% | 2.13K | ||
| -0.36% | -7.97% | -18.81% | -3.34% | 3.05B | ||
| -3.25% | -9.15% | +51.76% | +969.06% | 2.19B | ||
| -0.88% | -3.22% | -28.55% | -22.13% | 1.64B | ||
| +2.67% | 0.00% | +231.03% | +611.11% | 1.41B | ||
| -4.20% | -7.14% | -29.46% | +108.17% | 975M | ||
| +0.53% | -9.52% | +21.02% | +13.55% | 458M | ||
| +2.44% | -3.67% | +24.70% | +7.14% | 313M | ||
| +0.39% | -4.78% | +37.04% | +56.97% | 179M | ||
| +2.13% | +3.60% | +69.41% | +182.35% | 119M | ||
| Average | -0.05% | -4.74% | +35.82% | +192.29% | 1.03B | |
| Weighted average by Cap. | -0.84% | -6.52% | +32.83% | +298.34% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.45M 13.32M 12.47M 23.39M 1.55B 23.87M 160M 61.96M 769M 61.9M 60.55M 2.66B | 14.01M 12.29M 11.32M 10.6M 19.88M 1.32B 20.29M 136M 52.67M 653M 52.62M 51.47M 2.27B |
| Net income | -4.29M -3.76M -3.47M -3.25M -6.09M -405M -6.22M -41.69M -16.13M -200M -16.12M -15.76M -694M | -7.61M -6.67M -6.15M -5.76M -10.79M -718M -11.02M -73.9M -28.6M -355M -28.57M -27.94M -1.23B |
| Net Debt | 3.04M 2.67M 2.46M 2.3M 4.32M 287M 4.41M 29.56M 11.44M 142M 11.43M 11.18M 492M | 4.62M 4.05M 3.73M 3.49M 6.55M 435M 6.68M 44.83M 17.35M 215M 17.33M 16.95M 746M |
Employees
61
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















